分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer

Ruizhe He, Juanjuan Shi, Dapeng Xu, Jian Yang, Yang Shen, Yong-Sheng Jiang, Lingye Tao, Minwei Yang, Xueliang Fu, Jian-Yu Yang, Dejun Liu, Yanmiao Huo, Xuqing Shen, Ping Lu, Ningning Niu, Yong-Wei Sun, Jing Xue, Wei Liu

Journal:CANCER LETTERS

IF:9.76

DOI:10.1016/j.canlet.2022.215693

PMID:35472437

Published:2022-04-23

research field:

Abstract

Owing to the lack of early diagnosis, pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal tumours. Because acinar-to-ductal metaplasia (ADM) is a critical process to pancreatic regeneration and PDAC initiation, we applied GSE65146, a dataset composed of transcripts at different time points in wild-type and Kras G12D mutant mice upon pancreatitis induction, to obtain regeneration- and tumour initiation-related genes. By overlapping with genes differentially expressed in human PDAC, we defined the initiation- and progression-related genes, and the most prognostic gene, SULF2, was selected for further verification. By using multiple PDAC genetically engineered murine models (GEMMs), we further verified that the expression of SULF2 was increased at the ADM and PDAC stages. Functionally, SULF2 was able to promote the dedifferentiation of acinar cells as well as the metastatic ability of PDAC. Additionally, our study revealed that SULF2 could enhance TGFβ-SMAD signalling via GDF15. More importantly, serum SULF2 was elevated in patients with PDAC, and in combination with CA19-9, it provided a better method for PDAC diagnosis. Herein, our study screened out key genes for the initiation and progression of PDAC, providing potential indicators for the diagnosis of the disease.

本文使用的Yeasen产品

推荐应用
购物车
客服
转染试用